These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13047918)

  • 41. [ANOTHER SULFA PREPARATION: CLINICAL TEST OF 5-METHYL-3-SULFANILAMIDOISOXAZOLE].
    MUELLER L
    Sven Lakartidn; 1963 Oct; 60():3166-70. PubMed ID: 14053901
    [No Abstract]   [Full Text] [Related]  

  • 42. [Investigations on sensitivity of strains of Staphylococcus to sulfonamides].
    KRYNSKI S; BOROWSKI J; PREIS M; LALKO J
    Biul Panstw Inst Med Morsk Trop J W Gdansku; 1955; 6():161-6. PubMed ID: 13329818
    [No Abstract]   [Full Text] [Related]  

  • 43. [The chemical properties of sulfa-drugs].
    TUDA K
    Igaku; 1948 Oct; 3(131):7. PubMed ID: 18104792
    [No Abstract]   [Full Text] [Related]  

  • 44. Some observations on the mode of action of orinase.
    ARAI Y; ELRICK H; HLAD C; PRATT E; PURNELL R
    Metabolism; 1956 Nov; 5(6 Part 2):778-87. PubMed ID: 13378047
    [No Abstract]   [Full Text] [Related]  

  • 45. [Peripheral effect of new urea derivatives with hypoglycemic action].
    CANAL N; GARATTINI S; TESSARI L
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):491-4. PubMed ID: 13374139
    [No Abstract]   [Full Text] [Related]  

  • 46. A critical comparison of the antibacterial properties of commonly employed sulfonamides.
    FLORESTANO HJ; BAHLER ME
    J Am Vet Med Assoc; 1952 Dec; 121(909):474-7. PubMed ID: 13022532
    [No Abstract]   [Full Text] [Related]  

  • 47. Identification of antibacterial and antifungal pharmacophore sites for potent bacteria and fungi inhibition: indolenyl sulfonamide derivatives.
    Chohan ZH; Youssoufi MH; Jarrahpour A; Ben Hadda T
    Eur J Med Chem; 2010 Mar; 45(3):1189-99. PubMed ID: 20005022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of copper and silver ionization on fungal colonization of the water supply in health care centers: implications for immunocompromised patients.
    Pedro-Botet ML; Sanchez I; Sabria M; Sopena N; Mateu L; García-Núñez M; Rey-Joly C
    Clin Infect Dis; 2007 Jul; 45(1):84-6. PubMed ID: 17554706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Positive serologic reactions caused by sulfonamides and the behavior of blood proteins].
    GRANA A
    Soc Ital Dermatol Sifilogr Sezioni Interprov Soc Ital Dermatol Sifilogr; 1955; (1):46-8. PubMed ID: 13341735
    [No Abstract]   [Full Text] [Related]  

  • 50. [Research on bacteriostatic effect of blood sugar reducing substances and their excretion products].
    ORTEL S; MOHNIKE G
    Dtsch Med Wochenschr; 1956 Jun; 81(22):902-4. PubMed ID: 13344024
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antibiotics, sulfa and nitrofurans drugs].
    AGUIRRE C
    Cir Cir; 1957 Apr; 25(4):201-5. PubMed ID: 13447197
    [No Abstract]   [Full Text] [Related]  

  • 52. Synthesis, characterization and biological studies of sulfonamide Schiff's bases and some of their metal derivatives.
    Chohan ZH; Shad HA; Supuran CT
    J Enzyme Inhib Med Chem; 2012 Feb; 27(1):58-68. PubMed ID: 21534864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bacteriological investigations on N-hydroxymethyl-N'-(p-phthalimido)benzenesulfonyl-urea].
    GILLISSEN G; HO S
    Arzneimittelforschung; 1956 Aug; 6(8):432-6. PubMed ID: 13373638
    [No Abstract]   [Full Text] [Related]  

  • 54. A new bioactive Schiff base ligands derived from propylazo-N-pyrimidin-2-yl-benzenesulfonamides Mn(II) and Cu(II) complexes: synthesis, thermal and spectroscopic characterization biological studies and 3D modeling structures.
    Tawfik AM; El-Ghamry MA; Abu-El-Wafa SM; Ahmed NM
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():1172-80. PubMed ID: 22954685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues.
    BRITTON B; GRABOWSKI R; WICK AN
    Metabolism; 1956 Nov; 5(6 Part 2):739-43. PubMed ID: 13378041
    [No Abstract]   [Full Text] [Related]  

  • 56. Novel metal based anti-tuberculosis agent: synthesis, characterization, catalytic and pharmacological activities of copper complexes.
    Joseph J; Nagashri K; Janaki GB
    Eur J Med Chem; 2012 Mar; 49():151-63. PubMed ID: 22321994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Report of a lecture; the dangers of sulfa therapy].
    VAN ESSO I
    Geneeskd Gids; 1949 Dec; 27(25):475. PubMed ID: 15404194
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antibacterial effect and resorption of a sulfanilamide-penicillin combination (elkocillin)].
    ALLEMANN O
    Praxis; 1953 Mar; 42(12):229-33. PubMed ID: 13073788
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of fungistatic and bacteriostatic compounds on nonfilamentous marine phycomycetes.
    Belsky MM; Goldstein S
    Mycologia; 1965; 57(5):831-3. PubMed ID: 5829311
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical tests of the antidiabetic sulfa drugs.
    EICHBAUM FW
    Rev Bras Med; 1957 Jan; 14(1):5-11. PubMed ID: 13442028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.